News

Solarvest BioEnergy Inc.

439 Helmcken Street
Vancouver, BC
V6B 2E6
Canada

About Solarvest

Solarvest is committed to the development of sustainable and renewable energy sources to meet growing energy demands and environmental challenges. Solarvest's intellectual property is a biologically-based hydrogen producing technology, which provides a method for controlling key genes in algae resulting in the continuous production of hydrogen gas. Solarvest's bio-energy production system utilizes light and carbon dioxide to produce hydrogen leaving a clean positive environmental footprint.

For further information contact:

Gerri Greenham
Chief Executive Officer
T: +1 (416) 420-0947
E: Gerri Greenham

NEWS ARCHIVES

July 30, 2018
Report of exempt distribution excluding Schedule 1 of 45-106F1

July 27, 2018
News release – English

July 19, 2018
Report of exempt distribution excluding Schedule 1 of 45-106F1

July 17, 2018
News release – English

June 26, 2018
News release – English

June 25, 2018
52-109FV2 – Certification of interim filings – CEO (E)

June 25, 2018
52-109FV2 – Certification of interim filings – CFO (E)

June 25, 2018
MD&A – English

June 25, 2018
Interim financial statements/report - English

June 13, 2018
News release – English

June 8, 2018
News release – English

June 4, 2018
News release – English

May 18, 2018
News release – English

September 17, 2015
Solarvest’s NanuqTM Organic Omega-3 Receives FDA Approval

SEDAR
AN ARCHIVED LIST OF ALL FINANCIAL RECORDS AND NEWS RELEASES FOR SOLARVEST BIOENERGY INC. CAN BE FOUND AT WWW.SEDAR.COM

Spotlight

Solarvest BioEnergy specializes in the manipulation, growth and production of Chlamydomonas reinhardtii (below)